Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin
Haematologica. 2024 Jan 4.
doi: 10.3324/haematol.2023.284318.
Online ahead of print.
1 Departement of oncology, Geneva University Hospital, Geneva.
2 Laboratory of tumor immunology, Faculty of Medicine and Centre for Translational Research in Onco-Hematology, University of Geneva, Switzerland; Swiss Cancer Centre Léman.
3 SIB Swiss Institute of Bioinformatics.
4 Swiss Cancer Centre Léman, Switzerland; Clinical Pathology Service, Geneva University Hospital, Geneva.
5 Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Swiss Cancer Centre Léman.
6 Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Laboratory of tumor immunology, Faculty of Medicine and Centre for Translational Research in Onco-Hematology, University of Geneva, Switzerland; Swiss Cancer Centre Léman. pierre-yves.dietrich@hirslanden.ch.